BCI Pharma is a biotech company which focuses on the discovery and development of novel, highly potent and selective kinase inhibitors. Our aim is to bring new innovative treatments for neuropathic pain, psoriasis, endometriosis and cancer fields.
BCI Pharma is an innovative biopharmaceutical company focused on small molecule drug discovery. We design and synthesize innovative Kinase Inhibitors libraries and combine with our HTS technology (Target and cell-based assays). Thanks to our relevant platforms, we identify Novel, Potent and Selective Kinase Inhibitor Hits which are further optimized to preclinical candidates.
Contact: Dominique Surleraux
Tel: +33 6 74 26 73 34